BRONTE, Fabrizio
 Distribuzione geografica
Continente #
NA - Nord America 3.483
EU - Europa 1.431
AS - Asia 1.274
SA - Sud America 182
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 6.411
Nazione #
US - Stati Uniti d'America 3.432
SG - Singapore 539
RU - Federazione Russa 401
IT - Italia 289
CN - Cina 284
FI - Finlandia 176
BR - Brasile 149
HK - Hong Kong 134
DE - Germania 119
VN - Vietnam 102
UA - Ucraina 88
PL - Polonia 72
GB - Regno Unito 67
FR - Francia 62
IE - Irlanda 55
IN - India 42
JP - Giappone 33
BD - Bangladesh 31
CA - Canada 30
TR - Turchia 25
SE - Svezia 23
KR - Corea 21
RO - Romania 16
BE - Belgio 13
CI - Costa d'Avorio 11
AT - Austria 10
ES - Italia 10
NL - Olanda 10
PK - Pakistan 9
AR - Argentina 8
EC - Ecuador 7
ID - Indonesia 7
MX - Messico 7
LT - Lituania 6
PH - Filippine 6
ZA - Sudafrica 6
MY - Malesia 5
NP - Nepal 5
SA - Arabia Saudita 5
CL - Cile 4
CZ - Repubblica Ceca 4
IQ - Iraq 4
KE - Kenya 4
AZ - Azerbaigian 3
CO - Colombia 3
DZ - Algeria 3
EG - Egitto 3
JM - Giamaica 3
TN - Tunisia 3
UY - Uruguay 3
UZ - Uzbekistan 3
VE - Venezuela 3
CH - Svizzera 2
DO - Repubblica Dominicana 2
HN - Honduras 2
JO - Giordania 2
KZ - Kazakistan 2
LB - Libano 2
MA - Marocco 2
NI - Nicaragua 2
PE - Perù 2
PY - Paraguay 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AU - Australia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
DK - Danimarca 1
GH - Ghana 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
KY - Cayman, isole 1
MD - Moldavia 1
ML - Mali 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SI - Slovenia 1
SV - El Salvador 1
TH - Thailandia 1
Totale 6.411
Città #
Fairfield 454
Ashburn 449
Singapore 383
Woodbridge 232
Chandler 218
Houston 205
Seattle 183
Wilmington 176
Cambridge 155
Ann Arbor 151
San Jose 146
Hong Kong 129
Palermo 73
Moscow 63
Zgierz 60
Beijing 56
Dublin 55
New York 51
Jacksonville 49
Medford 49
Council Bluffs 48
Altamura 45
Los Angeles 44
Des Moines 42
Ho Chi Minh City 37
Hanoi 34
Princeton 32
Tokyo 32
Lawrence 31
Nanjing 31
Frankfurt am Main 28
San Diego 27
The Dalles 27
Lauterbourg 26
Dallas 24
Boardman 23
Helsinki 22
Santa Clara 22
Dearborn 17
Buffalo 16
Tulsa 16
London 14
São Paulo 14
Brussels 12
Chennai 12
Orem 12
Abidjan 11
Izmir 11
Phoenix 11
Jiaxing 10
Nanchang 10
Shenyang 10
Washington 10
Chicago 9
Milan 9
Changsha 8
Hebei 8
Hefei 8
Kumar 8
Ludwigshafen am Rhein 8
Paris 8
Rome 8
Atlanta 7
Ottawa 7
San Paolo di Civitate 7
Stockholm 7
Amsterdam 6
Belo Horizonte 6
Denver 6
Guangzhou 6
Jinan 6
Munich 6
Napoli 6
Saint Petersburg 6
Warsaw 6
Zhengzhou 6
Haiphong 5
Istanbul 5
Johannesburg 5
Montreal 5
Nuremberg 5
Poplar 5
Rio de Janeiro 5
Bologna 4
Boston 4
Brooklyn 4
Cagliari 4
Charlotte 4
Düsseldorf 4
Manchester 4
Nairobi 4
Norwalk 4
Nürnberg 4
San Francisco 4
Seoul 4
Shenzhen 4
Tampa 4
Toronto 4
Ancona 3
Auburn Hills 3
Totale 4.361
Nome #
HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals 330
Comparison of Histochemical Stainings in Evaluation of Liver Fibrosis and Correlation with Transient Elastography in Chronic Hepatitis 272
Quantification of fibrosis by collagen proportionate area predicts hepatic decompensation in hepatitis C cirrhosis 262
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma 261
Targeted Therapies in Hepatocellular Carcinoma 260
What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment 258
Cardiotoxicity mechanisms of the combination of BRAF-inhibitors and MEK-inhibitors 256
Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C. 249
Cost-Effectiveness of Boceprevir or Telaprevir for Untreated Patients with Genotype 1 Chronic Hepatitis C 237
IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection. 229
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B 'e' antigen-negative chronic hepatitis B genotype D. 229
Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy 229
Liver disease in chelated transfusion-dependent thalassemics: the role of iron and chronic hepatitis C 221
STAGING OF FIBROSIS BY LIVER STIFFNESS MEASUREMENT IN THALASSEMICS WITH IRON OVERLOAD 218
Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C. 216
Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy 200
NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients 199
HCV clearance among hemophiliacs and beta-thalassemics 198
Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) - lack of interference by iron deposition. 196
Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? the REAL Experience 196
Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: A meta-analysis. 193
Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication? 188
Point-of-care HCV RNA testing in the setting of DAA therapy: HCV-FiS (HEpatitis C Virus Fingerstick Study) 186
Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis 183
Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal varices in patients with compensated hepatitis C virus cirrhosis 182
Liver stiffness measurement by transient elastography predicts early recovery from acute hepatitis 175
Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis. 158
GENETIC, VIROLOGICAL AND CLINICAL FACTORS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA DEVELOPEMENT IN PATIENTS WITH CHRONIC HBV AND HCV INFECTION 152
HBsAg quantification in HBeAg negative cirrhosis on nucleoside/nucleotide analogue (NA) and risk of development of HCC 123
The risk of hepatocellular carcinoma in HBV cirrhosis is affected by polymorphisms of the MERTK gene 123
Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease 105
Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy 100
Totale 6.584
Categoria #
all - tutte 22.657
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.657


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022411 12 75 26 12 19 20 35 29 36 50 31 66
2022/2023558 51 138 6 69 58 84 33 29 49 2 24 15
2023/2024230 10 29 25 27 18 50 21 15 0 6 3 26
2024/2025549 13 25 19 49 30 15 51 32 38 54 92 131
2025/20262.296 148 63 114 201 252 371 338 216 165 240 100 88
2026/202750 50 0 0 0 0 0 0 0 0 0 0 0
Totale 6.584